๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chongqing
Clinical trial register · China

Clinical Trials in Chongqing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Chongqing 12 Haikou 3 Nanchang 3 Jingdezhen 2 Jiujiang 2
Narrow the registerReset
Recruitment status
Phase
Site location
Chongqing12 Haikou3 Nanchang3 Jingdezhen2 Jiujiang2
All 14 locations
Target enrolment
to

Trials with a site in Chongqing

12 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS)
NCT07682922Acute Ischemic Stroke
Xinqiao Hospital of Chongqing
Phase 4
1,040
Chongqing
2026-07-01
Not yet open
Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis
NCT07347626Acute Ischemic Stroke
Xinqiao Hospital of Chongqing
Phase 3
786
Chongqing, Haikou, Ganzhou, Jiโ€™an, Nanchang
2026-03-01
Recruiting
Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies
NCT07349849B-cell Malignancies
Xinqiao Hospital of Chongqing
Phase EARLY_PHASE1
47
Chongqing
2025-12-20
Recruiting
Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases
NCT06953843NSCLC Stage IV Without EGFR/ALK Mutation
Xinqiao Hospital of Chongqing
Phase 2
366
Chongqing
2025-07-09
Recruiting
A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases
NCT06947694NSCLC Stage IV Without EGFR/ALK Mutation
Xinqiao Hospital of Chongqing
Phase 2
427
Chongqing
2025-07-02
Recruiting
A Randomized Trial of Imaging Selection Modalities for Stroke Thrombectomy (NO-SELECT)
NCT05230914Stroke, Ischemic, Stroke, Acute
Xinqiao Hospital of Chongqing
Not applicable
1,846
Wuhu, Chongqing, Jiangmen, Haikou, Huai'an, Wuxi, Jingdezhen, Dalian
2024-12-12
Recruiting
Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
NCT06279351Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
Xinqiao Hospital of Chongqing
Phase 2
96
Chongqing
2024-08-11
Recruiting
A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies
NCT05862259Malignant Tumor, Immunotherapy, Artificial Intelligence
Xinqiao Hospital of Chongqing
Observational
120
Chongqing
2023-08-10
Recruiting
Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
NCT05754203Lung Cancer, Immune Checkpoint Inhibitor, Radiotherapy
Xinqiao Hospital of Chongqing
Not applicable
40
Chongqing
2023-08-01
Recruiting
Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis
NCT05455034Pneumonitis
Xinqiao Hospital of Chongqing
Phase 1/2
40
Chongqing
2023-08-01
Recruiting
An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment
NCT05486650Non Small Cell Lung Cancer
Xinqiao Hospital of Chongqing
Observational
20
Chongqing
2022-08-01
Recruiting
Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
NCT05147844Nasopharyngeal Carcinoma
Xinqiao Hospital of Chongqing
Phase 2
40
Chongqing
2022-03-01
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/chongqing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies with a site in Chongqing that also match the filters currently applied.

How many clinical trials are recruiting in Chongqing?

10 of the 12 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chongqing), 12 studies
PhaseStudiesRecruitingShare
Phase 24433.3%
Not applicable2216.7%
Observational2216.7%
Phase 1/2118.3%
Phase 3108.3%
Phase 4108.3%
Phase EARLY_PHASE1118.3%

Most active sponsors

Lead sponsors with the most studies (Chongqing)
Lead sponsorStudiesRecruiting
Xinqiao Hospital of Chongqing1210
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.